Benzoctamine
From Wikipedia, the free encyclopedia
 |
|
|
Benzoctamine
|
|
| Systematic (IUPAC) name | |
| N-methyl-9,10-ethanoanthracene-9(10H)-methanamine | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| Chemical data | |
| Formula | C18H19N |
| Mol. mass | 249.35 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | 2 to 3 hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | IV, oral |
Benzoctamine is a drug that possessess sedative and anxiolytic properties. It is different from most sedative drugs because in most clinical trials it does not produce respiratory depression, but actually stimulates the respiratory system. When co-administered with other drugs that cause respiratory depression, like morphine, it can cause increased respiratory depression. Peak effects are reached at about an hour, and effects wear off after about 2-3 hours. This drug is also used as a sedative in the hospital scene in patients who have respiratory failure.
[1]http://bja.oxfordjournals.org/cgi/content/abstract/47/9/987
[edit] References
- ^ BENZOCTAMINE-A STUDY OF THE RESPIRATORY EFFECTS OF ORAL DOSES IN HUMAN VOLUNTEERS AND INTERACTIONS WITH MORPHINE IN MICE - UTTING and PLEUVRY 47 (9): 987 - British Journal of Anaesthesia
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||
